Moderately bullish activity in Novo Nordisk (NVO), with shares up 32c, or 0.58%, near $56.59. Options volume running well above average with 161k contracts traded and calls leading puts for a put/call ratio of 0.83, compared to a typical level near 0.44. Implied volatility (IV30) is higher by 1.4 points near 45.97,and above the 52wk median, suggesting an expected daily move of $1.64. Put-call skew steepened, indicating increased demand for downside protection.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Eli Lilly Stock (LLY) Has 50% Upside, Says Citigroup
- LLY, JNJ, PFE: Big Pharma’s 2025 Comeback Is Bigger Than the Obesity Craze
- Novo Nordisk price target lowered to DKK 360 from DKK 375 at Barclays
- Novo Nordisk’s U.S. public affairs boss exits company, Reuters reports
- Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff